Epac CRISPR/Cas9 KO Plasmid (r): sc-437373
- Target species: rat
- 20 µg of transfection-ready, purified plasmid DNA; Suitable for up to 20 transfections
- Epac CRISPR/Cas9 Knockout (KO) Plasmid (r) is a pool of plasmids, each encoding Cas9 nuclease and a target-specific 20 nt guide RNA (gRNA) designed for maximum knockout efficiency using sequences derived from the GeCKO v2 library
- gRNA sequences direct Cas9 to induce site-specific double-strand breaks (DSBs) in the Epac genomic locus, resulting in gene knockout through non-homologous end joining (NHEJ)
- The puromycin resistance and RFP genes are flanked by LoxP sites, enabling removal of selection markers via Cre recombinase (Cre Vector: sc-418923) after establishing stable knockout cell lines
- Following transfection, gene knockout efficiency can be assayed by WB, IF or IHC using antibody: Epac Antibody (A-5): sc-28366
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Epac CRISPR/Cas9 KO Plasmid (r) | sc-437373 | 20 µg | $397.00 |
Overview
Epac (Exchange Protein Directly Activated by cAMP; RAPGEF3/RAPGEF4 family) is a cAMP-responsive guanine nucleotide exchange factor that activates Rap1 and Rap2 independently of PKA. Through Rap GTPase signaling, Epac regulates integrin-mediated adhesion, cytoskeletal remodeling, vesicle trafficking, and endothelial barrier properties, influencing cell migration and junctional stability. Epac-dependent cAMP pathways also intersect with MAPK/ERK and PI3K-AKT signaling to modulate inflammatory responses and cellular stress signaling. Dysregulated Epac-Rap signaling has been implicated in cardiovascular and neurobiological processes, including altered vascular permeability and neuronal excitability, supporting its use as a mechanistic target in rat disease-relevant models.
Epac CRISPR/Cas9 KO Plasmid (r) is a pool of plasmids designed for targeted disruption of the gene in rat cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Epac protein expression.
This CRISPR knockout system enables efficient generation of -deficient cell models for investigation of Epac signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
Key Features
- sgRNAs targeting exon(s) critical for Epac function
- Co-expression of SpCas9 and sgRNA from a single plasmid for simplified delivery
- GFP reporter for identification of transfected cells
- Pool of plasmids targeting multiple genomic sites to improve knockout efficiency
- Compatible with delivery by transfection
Design Variants
CRISPRs +/- HDRs
- gRNAs encoded by Epac CRISPR/Cas9 KO Plasmid (r) and Epac CRISPR/Cas9 KO Plasmid (r2) target distinct sites within the locus. One or both targeting designs may be available. See Related Products for availability.
- HDR donor constructs encoded by Epac HDR Plasmid (r) and Epac HDR Plasmid (r2) contain a puromycin resistance cassette and an RFP reporter flanked by homology arms to support homology-directed repair at defined target sites corresponding to the CRISPR/Cas9 KO designs. HDR donor availability may vary. See Related Products for availability.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.